s6y
Company name or ticker
Search
VERTEX PHARMACEUTICALS INC / MA
4
Kewalramani Reshma: Statement of changes in beneficial ownership of securities
Filed
Tuesday, November 10, 2026
Period
Nov 6, 2026
Accession number
0000875320-26-000293
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header